{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:40:38Z","timestamp":1791265238735,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cataract Refract Surg"],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To determine whether intracameral moxifloxacin 500 \u03bcg is noninferior to 250 \u03bcg for central endothelial cell loss (ECL) after phacoemulsification.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Aravind Eye Care System.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Prospective masked randomized study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Eyes with bilateral nuclear cataracts, central endothelial cell density (ECD) of more than 2000 cells\/mm<jats:sup>2<\/jats:sup>, and ECD not differing between eyes by more than 200 cells\/mm<jats:sup>2<\/jats:sup> underwent phacoemulsification at least 14 days apart. Intraoperatively, the first eye was randomized to receive either a 500 or 250 \u03bcg dose of moxifloxacin intracamerally and received the other dose for the second-eye surgery. Postoperative course was monitored at 1 day, 1 week, 1 month, and 3 months. Preoperative and 30-day and 90-day postoperative central ECD was determined by a reading center for a masked analysis of ECL at 3 months postoperatively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Fifty eyes of 25 patients (aged 48 to 69 years) underwent uneventful surgery and had normal postoperative courses. The point estimate (PE) and 95% CI for the mean difference in % ECL between the 500 \u03bcg and 250 \u03bcg doses at 3 months postoperatively was 0.8% (\u22125.8%, 7.4%). Upon identifying and removing 2 outliers, noninferiority was proven with a mean difference of the PE, \u22122.2% (CI, \u22126.5%, 2.1%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Clinical and corneal endothelial cell were comparable in this study population for the 250 \u03bcg and 500 \u03bcg doses of intracameral moxifloxacin. Both doses were well tolerated clinically, supporting the use of the higher dose for improved antimicrobial coverage for the prevention of postoperative endophthalmitis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/j.jcrs.0000000000000064","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T23:15:31Z","timestamp":1581030931000},"page":"355-359","source":"Crossref","is-referenced-by-count":20,"title":["Comparative corneal endothelial cell toxicity of differing intracameral moxifloxacin doses after phacoemulsification"],"prefix":"10.1097","volume":"46","author":[{"given":"David F.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Venkatesh","family":"Prajna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta B.","family":"Szczotka-Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth Ann","family":"Benetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan H.","family":"Lass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry J.","family":"Menegay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Shekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmila","family":"Rajendrababu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas J.","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230819","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ophtha.2015.12.011","article-title":"Intracameral antibiotics reduce the risk of endophthalmitis after cataract surgery: does the preponderance of the evidence mandate a global change in practice?","volume":"123","author":"Javitt","year":"2016","journal-title":"Ophthalmology"},{"key":"R2-20230819","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ophtha.2017.01.038","article-title":"A new complication associated with the use of prophylactic intracameral antibiotics: hemorrhagic occlusive retinal vasculitis","volume":"124","author":"Schwartz","year":"2017","journal-title":"Ophthalmology"},{"key":"R3-20230819","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/ICU.0000000000000445","article-title":"Intracameral antibiotics during cataract surgery: evidence and barriers","volume":"29","author":"Haripriya","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"key":"R4-20230819","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ophtha.2017.02.019","article-title":"Intracameral antibiotics in the shadow of hemorrhagic occlusive retinal vasculitis","volume":"124","author":"Naseri","year":"2017","journal-title":"Ophthalmology"},{"key":"R5-20230819","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.jcrs.2007.07.009","article-title":"Prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2007 ASCRS member survey","volume":"33","author":"Chang","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R6-20230819","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jcrs.2015.01.014","article-title":"Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2014 ASCRS member survey","volume":"41","author":"Chang","year":"2015","journal-title":"J Cataract Refract Surg"},{"key":"R8-20230819","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1016\/j.ophtha.2016.09.027","article-title":"Cataract in the adult eye Preferred Practice Pattern\u00ae","volume":"124","author":"Olson","year":"2017","journal-title":"Ophthalmology"},{"key":"R9-20230819","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ophtha.2016.11.042","article-title":"Vancomycin-associated hemorrhagic occlusive retinal vasculitis: clinical characteristics of 36 eyes","volume":"124","author":"Witkin","year":"2017","journal-title":"Ophthalmology"},{"key":"R10-20230819","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.jcrs.2014.10.010","article-title":"Intracameral antibiotics: safety, efficacy, and preparation","volume":"40","author":"Braga-Mele","year":"2014","journal-title":"J Cataract Refract Surg"},{"key":"R11-20230819","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ophtha.2017.01.026","article-title":"Endophthalmitis reduction with intracameral moxifloxacin prophylaxis: analysis of 600,000 surgeries","volume":"124","author":"Haripriya","year":"2017","journal-title":"Ophthalmology"},{"key":"R12-20230819","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jcrs.2019.04.018","article-title":"Endophthalmitis reduction with intracameral moxifloxacin in eyes with and without surgical complications: results from 2 million consecutive cataract surgeries","volume":"45","author":"Haripriya","year":"2019","journal-title":"J Cataract Refract Surg"},{"key":"R13-20230819","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.jcrs.2013.05.036","article-title":"Efficacy and safety of prophylactic intracameral moxifloxacin injection in Japan","volume":"39","author":"Matsuura","year":"2013","journal-title":"J Cataract Refract Surg"},{"key":"R14-20230819","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jcrs.2008.03.017","article-title":"Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery","volume":"34","author":"Arbisser","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"R15-20230819","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.jcrs.2016.10.017","article-title":"Dose and administration of intracameral moxifloxacin for prophylaxis of postoperative endophthalmitis","volume":"42","author":"Arshinoff","year":"2016","journal-title":"J Cataract Refract Surg"},{"key":"R16-20230819","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.jcrs.2008.05.034","article-title":"Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery","volume":"34","author":"Lane","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"R17-20230819","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcrs.2006.09.019","article-title":"Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients","volume":"33","author":"Espiritu","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R18-20230819","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1136\/bjophthalmol-2017-311051","article-title":"Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis","volume":"102","author":"Bowen","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"R19-20230819","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.jcrs.2014.08.027","article-title":"Comparison of toxicities of moxifloxacin, cefuroxime, and levofloxacin to corneal endothelial cells in vitro","volume":"40","author":"Haruki","year":"2014","journal-title":"J Cataract Refract Surg"},{"key":"R20-20230819","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jcrs.2017.04.028","article-title":"Endophthalmitis prophylaxis by intracameral antibiotics: in vitro model comparing vancomycin, cefuroxime, and moxifloxacin","volume":"43","author":"Libre","year":"2017","journal-title":"J Cataract Refract Surg"},{"key":"R21-20230819","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archopht.1993.01090060119035","article-title":"The Longitudinal Study of Cataract Study Group","volume":"111","author":"Chylack","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"R22-20230819","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/ICO.0000000000001826","article-title":"Corneal endothelial cell density and morphology after phacoemulsification in patients with primary open-angle glaucoma and cataracts: 2-year results of a randomized multicenter trial","volume":"38","author":"Ianchulev","year":"2019","journal-title":"Cornea"},{"key":"R24-20230819","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1001\/archopht.1992.01080200126039","article-title":"Correlation of histologic corneal endothelial cell counts with specular microscopic cell density","volume":"110","author":"Williams","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"R25-20230819","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/09286586.2016.1259636","article-title":"Tutorial on biostatistics: linear regression analysis of continuous correlated eye data","volume":"24","author":"Ying","year":"2017","journal-title":"Ophthalmic Epidemiol"},{"key":"R26-20230819","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.jcrs.2012.06.051","article-title":"Endothelial cell loss: biaxial small-incision torsional phacoemulsification versus biaxial small- incision longitudinal phacoemulsification","volume":"38","author":"Gonen","year":"2012","journal-title":"J Cataract Refract Surg"},{"key":"R27-20230819","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/archopht.1978.03910050222005","article-title":"The effect of phacoemulsification on corneal endothelial cell density","volume":"96","author":"Sugar","year":"1978","journal-title":"Arch Ophthalmol"},{"key":"R28-20230819","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/archopht.1980.01020040634009","article-title":"Specular microscopy in cataract and intraocular lens patients. A report of 564 cases","volume":"98","author":"Kraff","year":"1980","journal-title":"Arch Ophthalmol"}],"container-title":["Journal of Cataract and Refractive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/j.jcrs.0000000000000064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T08:20:29Z","timestamp":1692433229000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/j.jcrs.0000000000000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/j.jcrs.0000000000000064","relation":{},"ISSN":["0886-3350","1873-4502"],"issn-type":[{"value":"0886-3350","type":"print"},{"value":"1873-4502","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}